Ignite Creation Date:
2025-12-24 @ 3:16 PM
Ignite Modification Date:
2026-04-15 @ 1:03 PM
Study NCT ID:
NCT01442792
Status:
COMPLETED
Last Update Posted:
2022-06-23
First Post:
2011-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10-12
Start Date Type:
ACTUAL
Primary Completion Date:
2013-01-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03-04
Completion Date Type:
ACTUAL
First Submit Date:
2011-08-18
First Submit QC Date:
None
Study First Post Date:
2011-09-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-20
Last Update Post Date:
2022-06-23
Last Update Post Date Type:
ACTUAL